$28.910
-0.199 (-0.69%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACAD por análisis de gráficos similares
Alphio's ACAD stock price prediction model matches the current Acadia Pharmaceuticals Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.88 (-0.02%). The 1-week path is $27.94 (-3.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Acadia Pharmaceuticals Inc.?
ACADIA Pharmaceuticals is a good buy right now due to its recent EU approval for DAYBU, which is expected to significantly boost revenues. The current price of $29.11 is below several analyst price targets, such as $38 from Deutsche Bank and $40 from Citi. Additionally, the company has a strong gross margin of 90.81% and a forward P/E ratio of 71.94, suggesting growth potential despite current volatility.
ACAD cerró en $28.91 el Monday, tras bajar -0.69%
Acadia Pharmaceuticals Inc. (ACAD) last closed at $28.89, losing -0.07%. These facts feed the 1-day and 1-week ACAD price prediction above.
Consenso de analistas
Acadia Pharmaceuticals Inc. (ACAD): 8 comprar, 2 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Acadia Pharmaceuticals Inc. (ACAD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACAD, ordenadas por similitud.
Análisis de estacionalidad de ACAD
Historically the probability of a positive September return for ACAD is 52.38%. August offers the highest probability of a positive month at 64.06%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACAD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $26.80 | $28.30 | $28.97 | -2.06% |
| Oct 2026 | $21.38 | $22.99 | $25.36 | -20.42% |
| Nov 2026 | $22.81 | $28.51 | $30.75 | -1.31% |
| Dec 2026 | $19.57 | $21.36 | $26.83 | -26.06% |
En 2026, se proyecta que Acadia Pharmaceuticals Inc. (ACAD) oscile entre $19.57 y $30.75.
Previsión mensual de Acadia Pharmaceuticals Inc. para 2026
En Sep de 2026, se proyecta que Acadia Pharmaceuticals Inc. promedie $28.30, con un mínimo de $26.80 y un máximo de $28.97.
En Oct de 2026, se proyecta que Acadia Pharmaceuticals Inc. promedie $22.99, con un mínimo de $21.38 y un máximo de $25.36.
En Nov de 2026, se proyecta que Acadia Pharmaceuticals Inc. promedie $28.51, con un mínimo de $22.81 y un máximo de $30.75.
En Dec de 2026, se proyecta que Acadia Pharmaceuticals Inc. promedie $21.36, con un mínimo de $19.57 y un máximo de $26.83.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.